Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In

Clinical Trial Summary

Several studies have indicated a relation between the development of RVO and elevated intraocular pressure (IOP) and glaucoma [9]. Further investigations into the structural alterations in the fellow eyes of individuals with unilateral RVO have revealed that the pRNFL is thinner than in healthy eyes, suggesting that there may be systemic risk factors for both RVO and glaucoma

See also
Status	Clinical Trial	Phase
Completed	`NCT02390245` - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study	N/A
Active, not recruiting	`NCT04120311` - Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Not yet recruiting	`NCT04601688` - Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.	N/A
Completed	`NCT01968239` - Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT	Phase 2
Completed	`NCT00612261` - Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion	N/A
Not yet recruiting	`NCT03637283` - Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage	N/A
Completed	`NCT01976338` - Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)	Phase 3
Completed	`NCT01471691` - Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab	Phase 1/Phase 2
Completed	`NCT01247220` - REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study	Phase 2
Terminated	`NCT00642226` - Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)	Phase 3
Terminated	`NCT05127525` - EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)	Phase 3
Completed	`NCT01599650` - Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion	Phase 3
Active, not recruiting	`NCT04120636` - Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Recruiting	`NCT01975103` - Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases	Phase 2
Recruiting	`NCT01348633` - Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye	N/A
Completed	`NCT04740905` - A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion	Phase 3
Recruiting	`NCT02527733` - Retinal Sensitivity in BRVO After Anti-VEGF Therapy	Phase 4
Completed	`NCT01396057` - Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)	Phase 3
Terminated	`NCT03802630` - Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion	Phase 3
Completed	`NCT02478515` - Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion	Phase 4

NCT number	NCT06146309
Study type	Interventional
Source	Al-Azhar University
Contact
Status	Completed
Phase	N/A
Start date	December 1, 2020
Completion date	August 1, 2022

Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms